Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biomedicines|January 25, 2025
Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with M. bovis BCG or Other TherapiesInmaculada Ruiz-Lorente, Lourdes Gimeno, Alicia López-Abad, et al.
Cancer Immunology Research|June 27, 2019
Activating KIRs on Educated NK Cells Support Downregulation of CD226 and Inefficient Tumor ImmunosurveillanceConcepción F Guillamón, María V Martínez-Sánchez, Lourdes Gimeno, et al.
Oncoimmunology|December 12, 2025
HLA class-I genotyping to personalize Bacille Calmette-Guerin immunotherapy in bladder cancerInmaculada Ruiz-Lorente, Lourdes Gimeno, Alicia López-Abad, et al.
Archivos Espanoles De Urologia|November 25, 2004
[Hand-assisted laparoscopic radical nephrectomy vs. open nephrectomy in the treatment of clinically localized renal cell carcinoma. Comparative study]Pedro López Cubillana, Antonio Prieto González, Guillermo Gómez Gómez, et al.
European Urology Oncology|August 15, 2019
Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell BiomarkersConcepción F Guillamón, Lourdes Gimeno, Gerardo Server, et al.
Archivos Espanoles De Urologia|July 24, 2004
[Fatal evolution of a renal angiosarcoma]Pedro López Cubillana, Enrique Martínez Barba, Gerardo Server Pastor, et al.
Frontiers in Cell and Developmental Biology|September 22, 2025
Interplay of KIR2DL5, nitric oxide, and tobacco smoking in predisposition to bladder cancerInmaculada Ruiz-Lorente, Lourdes Gimeno, Alicia López-Abad, et al.
Journal of Clinical Medicine|October 26, 2024
Ultralow Prostate-Specific Antigen (PSA) Levels and Improved Oncological Outcomes in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Patients Treated with Apalutamide: A Real-World Multicentre StudyAlicia López-Abad, Mario Belmonte, Miguel Ramírez Backhaus, et al.
Cells|December 17, 2024
Exploring the Immunoresponse in Bladder Cancer ImmunotherapyInmaculada Ruiz-Lorente, Lourdes Gimeno, Alicia López-Abad, et al.
Prostate International|March 25, 2024
Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre studyAlicia López-Abad, Miguel Ramírez Backhaus, Gerardo Server Gómez, et al.
Pageof 2